Global Heart Valve Interventional Equipment Market Growth 2024-2030

Report ID: 2978622 | Published Date: Mar 2026 | No. of Page: 95 | Base Year: 2025 | Rating: 4 | Webstory: Check our Web story

Impact of U.S Tarrifs Analyzed 2025

Heart valve interventional equipment is a type of medical equipment used to treat heart valve diseases. The equipment is introduced into the patient's cardiovascular system through interventional surgery to repair or replace damaged or abnormal heart valves. These devices are designed to improve heart function and quality of life and reduce the occurrence of related complications in patients with heart valve disease.

The global Heart Valve Interventional Equipment market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime, Inc. (LPI) ' newest research report, the “Heart Valve Interventional Equipment Industry Forecast” looks at past sales and reviews total world Heart Valve Interventional Equipment sales in 2023, providing a comprehensive analysis by region and market sector of projected Heart Valve Interventional Equipment sales for 2024 through 2030.

With Heart Valve Interventional Equipment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Heart Valve Interventional Equipment industry.

This Insight Report provides a comprehensive analysis of the global Heart Valve Interventional Equipment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity.

Segmentation by Type:

  • Aortic Valve Interventional Equipment
  • Mitral Valve Interventional Equipment

Segmentation by Application:

  • General Hospital
  • Specialty Hospital
  • Others

This report also splits the market by region:

Americas

  • United States
  • Canada
  • Mexico
  • Brazil

APAC

  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia

Europe

  • Germany
  • France
  • UK
  • Italy
  • Russia

Middle East & Africa

  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

Companies Coverage:

  • Edwards Lifesciences
  • Medtronic
  • Sorin Group
  • Boston Scientific Corporation
  • LivaNova PLC
  • MicroPort Scientific Corporation
  • JenaValve Technology
  • Venus Medtech (Hangzhou)

Key Questions Addressed in this Report

  1. What is the 10-year outlook for the global Heart Valve Interventional Equipment market?
  2. What factors are driving Heart Valve Interventional Equipment market growth, globally and by region?
  3. Which technologies are poised for the fastest growth by market and region?
  4. How do Heart Valve Interventional Equipment market opportunities vary by end market size?
  5. How does Heart Valve Interventional Equipment break out by Type, by Application?
Frequently Asked Questions
Heart Valve Interventional Equipment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Heart Valve Interventional Equipment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Heart Valve Interventional Equipment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports